The MHRA (Medicines and Healthcare products Regulatory Agency) has announced major reforms that will speed up patient access to trusted medical technologies and make the United Kingdom a global leader in life sciences.

The new framework, which follows the Government's response to a public consultation, is designed to modernise the UK's medical device regulation, boost innovation (especially in AI-powered devices), and ensure patients benefit from cutting-edge technologies sooner.

Key Components of the Reforms:

• International Reliance Routes: The MHRA will introduce new pathways to allow medical devices approved by trusted regulators in countries like Australia, Canada, and the United States to enter the UK market more swiftly, reducing regulatory duplication.
• Focus on Innovation: The domestic UKCA route will be refocused on first-in-market, innovative technologies, including Artificial Intelligence (AI) as a medical device.
• Indefinite CE-Mark Recognition (Consultation): The MHRA plans to consult on the indefinite recognition of CE-marked devices, directly addressing industry feedback and providing clarity for manufacturers.
• Early Access Service: A new service is being established to provide time-limited, conditional access to innovative medical devices that address unmet clinical needs ahead of full regulatory approval.

 Official MHRA Links:

• Official Press Release on the Reforms:
  • MHRA announces proposals to improve access to world's best medical devices for patients and to boost economic growth in Britain's med tech sector (GOV.UK)
• Statement of Policy Intent: Early Access to Innovative Medical Devices:
  • MHRA outlines intent to speed up patient access to innovative medical devices (GOV.UK)
• General Guidance on Medical Devices Regulation in the UK:
  • Guidance on medical devices regulation (GOV.UK)